Filter
7647
Filtered Results: 7647
Text search:
World
Health
Organization
Africa
WHO
Featured
Recommendations
684
New Publications
1715
Language
Document type
No document type
3964
Studies & Reports
1601
Guidelines
883
Manuals
386
Strategic & Response Plan
301
Fact sheets
195
Training Material
122
Situation Updates
81
Resource Platforms
33
Infographics
27
Online Courses
23
Brochures
17
Dashboards/Maps
6
Videos
5
App
3
Countries / Regions
Global
394
Kenya
249
South Africa
242
Sierra Leone
206
Africa
196
Nigeria
186
Liberia
182
Ethiopia
178
Uganda
165
Zambia
130
Malawi
125
Tanzania
117
Rwanda
114
India
107
Congo, Democratic Republic of
106
Ghana
105
Latin America and the Carribbean
102
Middle East and North Africa
101
Namibia
92
Mozambique
89
West and Central Africa
89
Syria
81
South Sudan
79
East and Southern Africa
74
Western and Central Europe
71
Guinea
70
Lesotho
65
Senegal
64
Zimbabwe
63
Yemen
61
Nepal
59
Burkina Faso
50
Bangladesh
47
Russia
41
Cameroon
39
Ukraine
38
Botswana
37
Central African Republic
36
Brazil
35
Asia
34
Myanmar / Burma
32
Mali
31
Benin
30
South–East Asia Region
30
Sudan
30
Colombia
29
Angola
29
Eastern Europe
27
Indonesia
27
Eswatini/ Swaziland
27
Haiti
26
China
24
Somalia
23
Madagascar
23
Côte d’Ivoire / Ivory Coast
22
Cambodia
21
Venezuela
21
Germany
20
Philippines
18
Guinea-Bissau
17
Chad
17
Pakistan
17
Afghanistan
16
Thailand
13
Eastern Europe and Central Asia
13
Vietnam
12
Niger
11
Togo
10
Lebanon
10
Burundi
9
Jordan
9
North America
9
Iraq
9
Chile
8
Iran
8
Saudi Arabia
8
Southern Africa
8
Sri Lanka
8
Libya
8
Ecuador
8
Mexico
7
Gambia
7
Peru
7
Western Pacific Region
7
Paraguay
7
Egypt
7
Tunisia
6
Papua New Guinea
6
Morocco
5
Jamaica
5
Japan
5
Portugal
5
Albania
4
Laos
4
Mauritania
4
Greece
4
Palestine
4
Georgia
4
North Macedonia
3
Tajikistan
3
Serbia
3
Turkey
3
Kazakhstan
3
Kyrgyzstan
3
Malaysia
3
Qatar
3
USA
3
Gabon
3
France
3
Mauritius
3
Spain
3
Israel
3
Bosnia and Herzegovina
3
Argentina
3
Moldova
3
Djibouti
3
El Salvador
2
Canada
2
Congo-Brazzaville
2
Italy
2
Armenia
2
Turkmenistan
2
Belarus
2
Bolivia
2
Honduras
2
North Korea
1
Timor Leste/ East Timor
1
Estonia
1
Vanuatu
1
Mongolia
1
Bulgaria
1
Dominican Republic
1
Cape Verde
1
Croatia
1
Hungary
1
Uruguay
1
Denmark
1
Belgium
1
United Kingdom
1
Norway
1
Algeria
1
Morocco
1
Azerbaijan
1
Eritrea
1
Nicaragua
1
Romania
1
Poland
1
Solomon Islands
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2598
Clinical Guidelines
594
Public Health
413
Key Resources
412
Women & Child Health
404
Capacity Building
133
Pharmacy & Technologies
82
Annual Report MEDBOX
2
Toolboxes
HIV
718
COVID-19
660
Mental Health
494
TB
425
Ebola & Marburg
351
NTDs
320
Planetary Health
309
Disability
306
AMR
180
Caregiver
176
Global Health Education
174
Rapid Response
169
Conflict
149
Health Financing Toolbox
144
NCDs
144
Refugee
133
Malaria
128
Pharmacy
119
2.0 Rapid Response
78
Natural Hazards
67
Zika
59
Cholera
48
Polio
47
Social Ethics
27
Specific Hazards
23
Typhoon
3
South Sudan
2
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
July 2019
Policy brief
HIV Treatment
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Emergency response framework, 2nd ed.
recommended
The purpose of this Emergency Response Framework (ERF) is to clarify WHO’s roles and responsibilities in this regard and to provide a common approach for its work in emergencies. Ultimately, the ERF requires WHO to act with urgency and predictability to best serve and be accountable to populations...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
